{
    "2020-10-15": [
        [
            {
                "time": "",
                "original_text": "美年健康(002044.SZ)遭股东上海麒钧减持公司股份420.33万股 减持股份",
                "features": {
                    "keywords": [
                        "美年健康",
                        "上海麒钧",
                        "减持",
                        "420.33万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "美年健康：上海麒钧持股比例降至5%以下",
                "features": {
                    "keywords": [
                        "美年健康",
                        "上海麒钧",
                        "持股比例",
                        "5%以下"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "美年健康现2笔大宗交易 共成交415.28万元",
                "features": {
                    "keywords": [
                        "美年健康",
                        "大宗交易",
                        "415.28万元"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业日报：美国礼来暂停新冠抗体药物后期试验",
                "features": {
                    "keywords": [
                        "医药生物",
                        "美国礼来",
                        "新冠抗体药物",
                        "暂停",
                        "后期试验"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}